Phase 4 PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Military veterans between the ages of 18 and 75 who have both PTSD and Attention Deficit Disorder (ADHD), confirmed by specific symptom rating scores appropriate for their age group
- People who are in good enough physical health to take part in the study
- People who are able to understand the study and give their informed consent to participate
Who may not be able to join:
- People younger than 18 or older than 75
- People who are known to have a sensitivity or allergic reaction to the drug atomoxetine
- People with certain health conditions that could be made worse by atomoxetine, including a specific type of eye pressure problem (narrow angle closure glaucoma), difficulty passing urine, high blood pressure, nerve or muscle movement disorders such as tics or Tourette's syndrome, or a history of epilepsy or seizures
- People who have had a severe traumatic brain injury (though those with a mild traumatic brain injury may still be considered)
- People currently taking certain medications that could interact with atomoxetine, including a class of antidepressants called MAOIs, blood pressure medications, or certain other antidepressants such as paroxetine, fluoxetine, or venlafaxine
- People currently taking stimulant medications or certain other antidepressants, though those who stopped taking them at least two weeks before the trial starts may be considered
- People currently receiving another treatment that is working well for them, though continued standard therapies may be allowed if PTSD symptoms remain severe enough to meet the study's requirements (confirm with trial site)
- People with a current or past diagnosis of certain serious mental health conditions, including schizophrenia, schizoaffective disorder, psychotic disorders, or bipolar disorder (types I, II, or unspecified); depressive disorders linked to PTSD may be allowed
- People who have had a significant alcohol, marijuana, or other drug use disorder in the past three months, though occasional or recreational use that does not meet the level of a diagnosed disorder may be considered on a case-by-case basis
- People who are currently pregnant or planning to become pregnant during the trial period
- People who are currently experiencing strong thoughts of suicide or harming others, or who have made a suicide attempt in the past three months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhewu Wang, MD, Ralph H. Johnson VA Medical Center, Charleston, SC
Phone: (843) 789-7949
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Behavior Rating Inventory of Executive Function-Adult (BRIEF-A)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.